ArchiMed bought Natus Medical Natus Medical from 7/21/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

ArchiMed completed its acquisition of Natus Medical for $1.2 billion, or $33.5 per share.

Natus Medical

Review

Source:

{source} pictogram

investor.natus.com

Vladimir Petenev

News editor

News feed

KuibyshevAzot reported for 2024 by IFRS

4/3/25 KAZT

Astra is thinking about a buyback

4/3/25 ASTR

Winelab will go public in the medium term

4/3/25 BELU

Ozon Pharmaceuticals has introduced the drug Vildegra

4/3/25 OZPH

Yandex has launched Neuroexpert

4/3/25 YDEX

IVA Technologies reported for 2024 by IFRS

4/3/25 IVAT

Astra reported for 2024 by IFRS

4/3/25 ASTR

Abrau-Durso exited the cosmetics business

4/3/25 ABRD

Sistema JSFC reported for 2024 by RAS

4/3/25 AFKS

Rosdorbank shareholders bought out about a quarter of the additional share issue

4/2/25 RDRB